Salts and polymorphs of cyclic boronic acid ester derivatives and therapeutic uses thereof
US9687497B1 · kind B1 · utility
16Cited by
18References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 29, 2015 |
| Grant date | Jun 27, 2017 |
| Priority date | — |
| Expiry date | Apr 29, 2035 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein is the crystalline form of the potassium salt of 2-((3R,6S)-2-hydroxy-3-(2-(thiophen-2-yl)acetamido)-1,2-oxaborinan-6-yl)acetic acid. The crystalline form maybe formulated for treating subjects with bacterial infection. Accordingly, some embodiments relate to compositions and methods of administering the potassium salt of 2-((3R,6S)-2-hydroxy-3-(2-(thiophen-2-yl)acetamido)-1,2-oxaborinan-6-yl)acetic acid.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.